Internationalvaccineinstitute

04/08/2019

Student engagement program cited by foreign school

  IVI has been featured in Seoul Foreign School’s Work Experience Program brochure. In May of 2018, eleven SFS students participated in the program with support from volunteer Dr. Silvia Kim. They learned basic techniques in cellular immunology in the IVI labs and had the […]
04/09/2019

IVI DG gives keynote at ‘International Symposium on Epidemics Preparedness Using ICT’

Key attendees pose for a commemorative photo   Dr. Jerome Kim delivers his keynote address   IVI Director General Dr. Jerome Kim was invited as a keynote speaker at the ‘International Symposium on Epidemics Preparedness Using ICT’ at the Korean National Assembly on April 3, […]
04/09/2019

EuBiologics inaugurates 2nd manufacturing plant in Chuncheon, Korea

Dr. Baik Yeong-Ok, CEO of EuBiologics, and Dr. Jerome Kim, Director General of IVI pose together at the inauguration of EuBiologics’ Second Plant in Chuncheon, Korea on April 9, 2019.   EuBiologics, the manufacturer of Euvichol® and Euvichol-Plus® oral cholera vaccine, and an important partner […]
04/12/2019

Experts find evidence of underfunding in rheumatic heart disease research

IVI’s Director General, Dr. Jerome Kim was a member of the team of experts that looked at the underfunding of rheumatic heart disease (RHD) research.   RHD, a long-term consequence of Streptococcus pyogenes (Group A streptococcus, or GAS) infection, is estimated to affect at least 33 […]